Ray Dalio's position in NovoCure Ltd is currently worth $1.04 Million. That's 0.01% of their equity portfolio (616th largest holding). The first NovoCure Ltd trade was made in Q2 2021. Since then Ray Dalio bought shares five more times and sold shares on five occasions. The investor's estimated purchase price is $9.51 Million, resulting in a loss of 89%.